Home
Browse
Search
Statistics
About
Usage
PMID: 21642448
Caldwell RA, Grove DE, Houck SA, Cyr DM
Increased folding and channel activity of a rare cystic fibrosis mutant with CFTR modulators.
Am J Physiol Lung Cell Mol Physiol. 2011 Sep;301(3):L346-52. Epub 2011 Jun 3.,
[PubMed]
Sentences
No.
Mutations
Sentence
Comment
35
ABCC7 p.Val232Asp
X
ABCC7 p.Val232Asp 21642448:35:33
status:
NEW
view ABCC7 p.Val232Asp details
The folding defect caused by the
V232D
mutation appears to be due to the introduction of a charged residue into a region of CFTR that is embedded in the lipid bilayer of the ER membrane (17, 24).
Login to comment
36
ABCC7 p.Val232Asp
X
ABCC7 p.Val232Asp 21642448:36:47
status:
NEW
view ABCC7 p.Val232Asp details
Since the folding defect in CFTR caused by the
V232D
mutation is correctable to wild-type levels, CF patients with this allele may benefit from treatment with folding correctors.
Login to comment
37
ABCC7 p.Val232Asp
X
ABCC7 p.Val232Asp 21642448:37:33
status:
NEW
view ABCC7 p.Val232Asp details
The folding defect caused by the
V232D
mutation appears to be due to the introduction of a charged residue into a region of CFTR that is embedded in the lipid bilayer of the endoplasmic reticulum (ER) membrane (17, 24).
Login to comment
38
ABCC7 p.Val232Asp
X
ABCC7 p.Val232Asp 21642448:38:47
status:
NEW
view ABCC7 p.Val232Asp details
Since the folding defect in CFTR caused by the
V232D
mutation is correctable to wild-type levels, CF patients with this allele may benefit from treatment with folding correctors.
Login to comment
154
ABCC7 p.Val232Asp
X
ABCC7 p.Val232Asp 21642448:154:32
status:
NEW
view ABCC7 p.Val232Asp details
Yet, the mechanism by which the
V232D
mutation causes CF is not well documented and whether patients with this mutation can be treated with modulators of CFTR folding and channel activity is not clear.
Login to comment
156
ABCC7 p.Val232Asp
X
ABCC7 p.Val232Asp 21642448:156:4
status:
NEW
view ABCC7 p.Val232Asp details
The
V232D
mutation is proposed to cause aberrant hydrogen bonding between TM4 and adjacent TM segments in CFTR (24).
Login to comment
165
ABCC7 p.Val232Asp
X
ABCC7 p.Val232Asp 21642448:165:63
status:
NEW
view ABCC7 p.Val232Asp details
Thus, CF patients that harbor low frequency mutations, such as
V232D
, might be treated with small molecules that correct CFTR misfolding or potentiate CFTR channel activity.
Login to comment
169
ABCC7 p.Val232Asp
X
ABCC7 p.Val232Asp 21642448:169:37
status:
NEW
view ABCC7 p.Val232Asp details
In doing so, Corr-4a may prevent the
V232D
mutation from causing the aberrant hydrogen bonding between TM segments in the bilayer proposed to cause premature degradation of CFTRV232D (24).
Login to comment
191
ABCC7 p.Val232Asp
X
ABCC7 p.Val232Asp 21642448:191:31
status:
NEW
view ABCC7 p.Val232Asp details
Yet the mechanism by which the
V232D
mutation causes CF is not well documented, and whether patients with this mutation can be treated with modulators of CFTR folding and channel activity is not clear.
Login to comment
193
ABCC7 p.Val232Asp
X
ABCC7 p.Val232Asp 21642448:193:4
status:
NEW
view ABCC7 p.Val232Asp details
The
V232D
mutation is proposed to cause aberrant hydrogen bonding between TM4 and adjacent TM segments in CFTR (24).
Login to comment
202
ABCC7 p.Val232Asp
X
ABCC7 p.Val232Asp 21642448:202:62
status:
NEW
view ABCC7 p.Val232Asp details
Thus CF patients that harbor low-frequency mutations, such as
V232D
, might be treated with small molecules that correct CFTR misfolding or potentiate CFTR channel activity.
Login to comment
206
ABCC7 p.Val232Asp
X
ABCC7 p.Val232Asp 21642448:206:37
status:
NEW
view ABCC7 p.Val232Asp details
In doing so, Corr-4a may prevent the
V232D
mutation from causing the aberrant hydrogen bonding between TM segments in the bilayer proposed to cause premature degradation of CFTRV232D (24).
Login to comment